These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37490021)

  • 1. The anti-inflammatory and haemodynamic effects of levosimendan on advanced heart failure patients: a meta-analysis of published studies.
    Zhou S; Li D; Zhang L; Li J
    J Int Med Res; 2023 Jul; 51(7):3000605221148402. PubMed ID: 37490021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of levosimendan in patients with acute decompensated heart failure : A meta-analysis.
    Zhou S; Zhang L; Li J
    Herz; 2019 Nov; 44(7):630-636. PubMed ID: 29637229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levosimendan Can Improve the Level of B-Type Natriuretic Peptide and the Left Ventricular Ejection Fraction of Patients with Advanced Heart Failure: A Meta-analysis of Randomized Controlled Trials.
    Cui D; Liao Y; Li G; Chen Y
    Am J Cardiovasc Drugs; 2021 Jan; 21(1):73-81. PubMed ID: 32462455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic effects of levosimendan in advanced but stable chronic heart failure.
    Najjar E; Stålhberg M; Hage C; Ottenblad E; Manouras A; Haugen Löfman I; Lund LH
    ESC Heart Fail; 2018 Jun; 5(3):302-308. PubMed ID: 29469177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rehospitalization after intermittent levosimendan treatment in advanced heart failure patients: a meta-analysis of randomized trials.
    Silvetti S; Belletti A; Fontana A; Pollesello P
    ESC Heart Fail; 2017 Nov; 4(4):595-604. PubMed ID: 28834396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers.
    Bergh CH; Andersson B; Dahlström U; Forfang K; Kivikko M; Sarapohja T; Ullman B; Wikström G
    Eur J Heart Fail; 2010 Apr; 12(4):404-10. PubMed ID: 20335355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease.
    Hummel J; Rücker G; Stiller B
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011312. PubMed ID: 28262914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levosimendan in patients with cardiogenic shock complicating myocardial infarction: A meta-analysis.
    Fang M; Cao H; Wang Z
    Med Intensiva (Engl Ed); 2018 Oct; 42(7):409-415. PubMed ID: 29126662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic interactions of a new calcium sensitizing drug levosimendan and captopril.
    Antila S; Eha J; Heinpalu M; Lehtonen L; Loogna I; Mesikepp A; Planken U; Sandell EP
    Eur J Clin Pharmacol; 1996; 49(6):451-8. PubMed ID: 8706769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of levosimendan on clinical outcomes in adult patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials.
    Zhou X; Hu C; Xu Z; Liu P; Zhang Y; Sun L; Wang Y; Gao X
    Interact Cardiovasc Thorac Surg; 2018 Jun; 26(6):1016-1026. PubMed ID: 29415177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators.
    Slawsky MT; Colucci WS; Gottlieb SS; Greenberg BH; Haeusslein E; Hare J; Hutchins S; Leier CV; LeJemtel TH; Loh E; Nicklas J; Ogilby D; Singh BN; Smith W
    Circulation; 2000 Oct; 102(18):2222-7. PubMed ID: 11056096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent levosimendan improves mid-term survival in chronic heart failure patients: meta-analysis of randomised trials.
    Silvetti S; Greco T; Di Prima AL; Mucchetti M; de Lurdes CM; Pasin L; Scandroglio M; Landoni G; Zangrillo A
    Clin Res Cardiol; 2014 Jul; 103(7):505-13. PubMed ID: 24368740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent levosimendan infusion in ambulatory patients with end-stage heart failure: a systematic review and meta-analysis of 984 patients.
    Elsherbini H; Soliman O; Zijderhand C; Lenzen M; Hoeks SE; Kaddoura R; Izham M; Alkhulaifi A; Omar AS; Caliskan K
    Heart Fail Rev; 2022 Mar; 27(2):493-505. PubMed ID: 33839989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated infusions of levosimendan: well tolerated and improves functional capacity in decompensated heart failure - a single-centre experience.
    Parle NM; Thomas MD; Dembo L; Best M; Driscoll GO
    Heart Lung Circ; 2008 Jun; 17(3):206-10. PubMed ID: 18242130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levosimendan Improves Clinical Outcomes of Refractory Heart Failure in Elderly Chinese Patients.
    Zhang D; Yao Y; Qian J; Huang J
    Med Sci Monit; 2015 Aug; 21():2439-45. PubMed ID: 26289557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levosimendan for Prevention of Acute Kidney Injury After Cardiac Surgery: A Meta-analysis of Randomized Controlled Trials.
    Zhou C; Gong J; Chen D; Wang W; Liu M; Liu B
    Am J Kidney Dis; 2016 Mar; 67(3):408-16. PubMed ID: 26518388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is levosimendan effective in paediatric heart failure and post-cardiac surgeries?
    Angadi U; Westrope C; Chowdhry MF
    Interact Cardiovasc Thorac Surg; 2013 Oct; 17(4):710-4. PubMed ID: 23832921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levosimendan and mortality after coronary revascularisation: a meta-analysis of randomised controlled trials.
    Maharaj R; Metaxa V
    Crit Care; 2011 Jun; 15(3):R140. PubMed ID: 21651806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.
    Follath F; Cleland JG; Just H; Papp JG; Scholz H; Peuhkurinen K; Harjola VP; Mitrovic V; Abdalla M; Sandell EP; Lehtonen L;
    Lancet; 2002 Jul; 360(9328):196-202. PubMed ID: 12133653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.